A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China

Clinical trial NCT04121286 · COMPLETED

Trial details

NCT number: NCT04121286
Sponsor: Allist Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Colorectal Cancer Pancreatic Ductal Carcinoma Esophageal Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma Breast Cancer Other Solid Tumors

Start date: 2020-07-14
Primary completion: 2022-06-17
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.